A Prospective Evaluation of the Cingal Injection for Hip Osteoarthritis

A Prospective Evaluation of the Cingal Injection for Hip Osteoarthritis (ECHO Study)

Osteoarthritis (OA) of the hip is one of the ten most disabling diseases in the developed world. Because OA gradually worsens over time, the sooner treatment is started, the more likely its impact is lessened. Hip OA is characterized by joint pain, cartilage degeneration, and an increase in disability. Multiple treatments are used to manage the degenerating hip as well as the associated pain. These include physiotherapy and rehabilitation, bracing, other walking aids, oral medications, injections, and in severe cases, surgery. Prior research has shown that injection of hyaluronic acid (HA) and corticosteroids can slow down OA degradation. This study will look at the effects of injecting Cingal into the hip, which expands on its current approved use in the treatment of knee OA.

A Prospective Evaluation of the Cingal Injection for Hip Osteoarthritis

Recruitment

Summary

Participation Requirements

Description

Tracking Information